Last reviewed · How we verify

Epikeia coatings with aspirin

Biomedical Development Corporation · Phase 1 active Small molecule

Epikeia coatings with aspirin is a Small molecule drug developed by Biomedical Development Corporation. It is currently in Phase 1 development. Also known as: Epikeia coatings with acetylsalicylic acid.

At a glance

Generic nameEpikeia coatings with aspirin
Also known asEpikeia coatings with acetylsalicylic acid
SponsorBiomedical Development Corporation
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Epikeia coatings with aspirin

What is Epikeia coatings with aspirin?

Epikeia coatings with aspirin is a Small molecule drug developed by Biomedical Development Corporation.

Who makes Epikeia coatings with aspirin?

Epikeia coatings with aspirin is developed by Biomedical Development Corporation (see full Biomedical Development Corporation pipeline at /company/biomedical-development-corporation).

Is Epikeia coatings with aspirin also known as anything else?

Epikeia coatings with aspirin is also known as Epikeia coatings with acetylsalicylic acid.

What development phase is Epikeia coatings with aspirin in?

Epikeia coatings with aspirin is in Phase 1.

Related